August 23, 2022
1 min read
Save
Vascular closure system utilizing plant-derived hemostatic foam gains FDA clearance
KOAG LLC, a Minneapolis-based medical device firm, announced it received FDA clearance for its topical vascular closure system.
The system (Vascette HP) is a topical closure pad incorporating a plant-derived hemostatic foam to support rapid hemostasis following cardiac catheterization without direct compression over the arterial puncture site, according to a press release issued by the company.
The company stated it will exhibit the topical closure pad at the Association for Vascular Access congress in Minneapolis, Sept. 30 through Oct 2, 2022.
Published by: